Evaluation of the clinical value of contrast enhanced ultrasound in the diagnostic and follow-up of renal cell cancer

Evaluation of the clinical value of contrast enhanced ultrasound in the diagnostic and follow-up of renal cell cancer - Contrast enhanced ultrasound in renal cell carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31004

Enrollment

100

Registered

2007-08-17

Start date

2006-03-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal cancer renal cell carinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with renal cell carcinoma who wil be operated or patients with complicated cysts who will be followed-up

Exclusion criteria

Exclusion criteria: severe cardial co-morbidity, New York Heart Association class IV cardiac failure.

Design outcomes

Primary

Measure	Time frame
Our primary objective is to establish the diagnostic accuracy of CE-US in renal masses suspicious for RCC.	—

Secondary

Measure	Time frame
Our secondary objective is to establish the pattern of vascularisation in the different sub-types of RCC.	—

Countries

Netherlands

Outcome results